Rational study endpoint(s) for preoperative trials in pancreatic cancer: Pathologic response rate, margin negative resection, overall survival or 'all of the above'?

Gauri R. Varadhachary; Douglas B. Evans

doi:10.1245/s10434-013-3165-5

Rational study endpoint(s) for preoperative trials in pancreatic cancer: Pathologic response rate, margin negative resection, overall survival or 'all of the above'?

Gauri R. Varadhachary
, Douglas B. Evans

GI Medical Oncology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	3712-3714
Number of pages	3
Journal	Annals of surgical oncology
Volume	20
Issue number	12
DOIs	https://doi.org/10.1245/s10434-013-3165-5
State	Published - Nov 2013

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-013-3165-5

Cite this

@article{637cf945f4254aceb0d815ec493aaf88,

title = "Rational study endpoint(s) for preoperative trials in pancreatic cancer: Pathologic response rate, margin negative resection, overall survival or 'all of the above'?",

author = "Varadhachary, \{Gauri R.\} and Evans, \{Douglas B.\}",

year = "2013",

month = nov,

doi = "10.1245/s10434-013-3165-5",

language = "English (US)",

volume = "20",

pages = "3712--3714",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "12",

}

TY - JOUR

T1 - Rational study endpoint(s) for preoperative trials in pancreatic cancer

T2 - Pathologic response rate, margin negative resection, overall survival or 'all of the above'?

AU - Varadhachary, Gauri R.

AU - Evans, Douglas B.

PY - 2013/11

Y1 - 2013/11

UR - https://www.scopus.com/pages/publications/84886100127

UR - https://www.scopus.com/pages/publications/84886100127#tab=citedBy

U2 - 10.1245/s10434-013-3165-5

DO - 10.1245/s10434-013-3165-5

M3 - Review article

C2 - 23943023

AN - SCOPUS:84886100127

SN - 1068-9265

VL - 20

SP - 3712

EP - 3714

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 12

ER -

Rational study endpoint(s) for preoperative trials in pancreatic cancer: Pathologic response rate, margin negative resection, overall survival or 'all of the above'?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this